Nonoperating Income (Expense) in USD of PLUS THERAPEUTICS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
PLUS THERAPEUTICS, INC. quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2010 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $59K, a 93.6% decline year-over-year.
  • PLUS THERAPEUTICS, INC. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was -$7.12M, a 503% decline year-over-year.
  • PLUS THERAPEUTICS, INC. annual Nonoperating Income (Expense) for 2024 was $1.72M, a 34240% increase from 2023.
  • PLUS THERAPEUTICS, INC. annual Nonoperating Income (Expense) for 2023 was $5K.
  • PLUS THERAPEUTICS, INC. annual Nonoperating Income (Expense) for 2022 was -$563K, a 37.9% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$7.12M $59K -$866K -93.6% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$6.25M $6.69M +$5.93M +784% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$12.2M -$13.9M -$13.9M -36587% 01 Jan 2025 31 Mar 2025 10-Q 30 May 2025
Q4 2024 $1.72M -$3K -$51K -106% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $1.77M $925K +$893K +2791% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $875K $757K +$749K +9363% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $126K $38K +$121K 01 Jan 2024 31 Mar 2024 10-Q 30 May 2025
Q4 2023 $5K $48K +$134K 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$129K $32K +$157K 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$286K $8K +$170K 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$456K -$83K +$107K +56.3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$563K -$86K +$130K +60.2% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 -$693K -$125K +$100K +44.4% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023
Q2 2022 -$793K -$162K +$63K +28% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$856K -$190K +$51K +21.2% 01 Jan 2022 31 Mar 2022 10-Q 20 Apr 2023
Q4 2021 -$907K -$216K -$24K -12.5% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 -$883K -$225K +$107K +32.2% 01 Jul 2021 30 Sep 2021 10-Q 20 Oct 2022
Q2 2021 -$990K -$225K -$738K -144% 01 Apr 2021 30 Jun 2021 10-Q 21 Jul 2022
Q1 2021 -$252K -$241K -$1.6M -118% 01 Jan 2021 31 Mar 2021 10-Q 21 Apr 2022
Q4 2020 $1.34M -$192K -$3.33M -106% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $4.67M -$332K +$1.82M +84.6% 01 Jul 2020 30 Sep 2020 10-Q 21 Oct 2021
Q2 2020 $2.85M $513K +$821K 01 Apr 2020 30 Jun 2020 10-Q 22 Jul 2021
Q1 2020 $2.03M $1.35M +$1.65M 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021
Q4 2019 $374K $3.13M +$3.23M 01 Oct 2019 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 -$2.86M -$2.15M -$2.99M -359% 01 Jul 2019 30 Sep 2019 10-Q 22 Oct 2020
Q2 2019 $126K -$308K +$131K +29.8% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$5K -$298K +$111K +27.1% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$116K -$99K +$557K +84.9% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 -$673K $831K +$1.3M 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$1.97M -$439K +$29K +6.2% 01 Apr 2018 30 Jun 2018 10-Q 15 Aug 2019
Q1 2018 -$2M -$409K +$6K +1.45% 01 Jan 2018 31 Mar 2018 8-K 10 Sep 2019
Q4 2017 -$2M -$656K +$674K +50.7% 01 Oct 2017 31 Dec 2017 10-K 09 Mar 2018
Q3 2017 -$2.68M -$464K +$123K +21% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$2.8M -$468K -$287K -159% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$2.51M -$415K -$173K -71.5% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 -$2.34M -$1.33M -$645K -94.2% 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 -$1.7M -$587K -$117K -24.9% 01 Jul 2016 30 Sep 2016 10-K 09 Mar 2018
Q2 2016 -$1.58M -$181K +$1.16M +86.5% 01 Apr 2016 30 Jun 2016 10-K 09 Mar 2018
Q1 2016 -$2.74M -$242K +$719K +74.8% 01 Jan 2016 31 Mar 2016 10-K 09 Mar 2018
Q4 2015 -$3.46M -$685K +$755K +52.4% 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 -$4.21M -$470K +$1.03M +68.6% 01 Jul 2015 30 Sep 2015 10-K 24 Mar 2017
Q2 2015 -$5.24M -$1.34M -$199K -17.4% 01 Apr 2015 30 Jun 2015 10-K 24 Mar 2017
Q1 2015 -$5.04M -$961K -$108K -12.7% 01 Jan 2015 31 Mar 2015 10-K 24 Mar 2017
Q4 2014 -$4.93M -$1.44M -$517K -56% 01 Oct 2014 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 -$4.41M -$1.5M -$4.7M -147% 01 Jul 2014 30 Sep 2014 10-K 11 Mar 2016
Q2 2014 $284K -$1.14M -$4.3M -136% 01 Apr 2014 30 Jun 2014 10-K 11 Mar 2016
Q1 2014 $4.58M -$853K +$77K +8.28% 01 Jan 2014 31 Mar 2014 10-K 11 Mar 2016
Q4 2013 $4.5M -$923K +$139K +13.1% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $4.36M $3.2M +$4.12M 01 Jul 2013 30 Sep 2013 10-K 16 Mar 2015
Q2 2013 $244K $3.15M +$4.08M 01 Apr 2013 30 Jun 2013 10-K 16 Mar 2015
Q1 2013 -$3.83M -$930K +$30K +3.13% 01 Jan 2013 31 Mar 2013 10-K 16 Mar 2015
Q4 2012 -$3.86M -$1.06M -$130K -13.9% 01 Oct 2012 31 Dec 2012 10-K 14 Mar 2014
Q3 2012 -$3.73M -$916K -$404K -78.9% 01 Jul 2012 30 Sep 2012 10-K 14 Mar 2014
Q2 2012 -$3.33M -$923K -$157K -20.5% 01 Apr 2012 30 Jun 2012 10-K 14 Mar 2014
Q1 2012 -$3.17M -$960K -$131K -15.8% 01 Jan 2012 31 Mar 2012 10-K 14 Mar 2014
Q4 2011 -$3.04M -$932K 01 Oct 2011 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 -$512K +$314K +38% 01 Jul 2011 30 Sep 2011 10-K 15 Mar 2013
Q2 2011 -$766K -$431K -129% 01 Apr 2011 30 Jun 2011 10-K 15 Mar 2013
Q1 2011 -$829K 01 Jan 2011 31 Mar 2011 10-K 15 Mar 2013
Q3 2010 -$826K 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011
Q2 2010 -$335K 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

PLUS THERAPEUTICS, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.72M +$1.71M +34240% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $5K +$568K 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$563K +$344K +37.9% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$907K -$2.25M -168% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 $1.34M +$969K +259% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
2019 $374K +$490K 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2021
2018 -$116K +$1.9M +94.2% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$2.02M +$324K +13.8% 01 Jan 2017 31 Dec 2017 8-K 10 Sep 2019
2016 -$2.34M +$1.12M +32.3% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018
2015 -$3.46M +$1.47M +29.9% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 -$4.93M -$9.43M -210% 01 Jan 2014 31 Dec 2014 10-K 11 Mar 2016
2013 $4.5M +$8.36M 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 -$3.86M -$822K -27% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 -$3.04M -$868K -40% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 -$2.17M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.